MedTrace Logo

Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment

NCT01739972 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2012-12-04

No results posted yet for this study

Summary

Our hypothesis is that hypothyroid patients on DTE may have a decrease in symptoms, an improvement of cognitive function, and an increase in sense of well-being/ quality of life equivalently compared with L-T4.

Conditions

  • Primary Hypothyroidism.

Interventions

DRUG

Levothyroxine

Levothyroxine in a capsule form, once daily, with appropriate dosage to keep TSH in the normal range.

DRUG

Desiccated thyroid extract

Armour thyroid in a capsule form, once daily, with appropriate dosage to keep TSH in normal range.

Sponsors & Collaborators

  • Walter Reed National Military Medical Center

    lead FED

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01739972 on ClinicalTrials.gov